Nutt David J
University of Bristol, Psychopharmacology Unit, Bristol, UK.
Hum Psychopharmacol. 2002 Jun;17 Suppl 1:S37-41. doi: 10.1002/hup.388.
The tolerability and safety profile of the noradrenergic and specific serotonergic antidepressant (NaSSA) mirtazapine reflects its unique pharmacological profile. The 5-HT(2) blocking effect contributes towards its anxiolytic effects and benefits on sleep, as well as preventing the sexual dysfunction that may occur with non-specific stimulation of the serotonin system by drugs such as the selective serotonin reuptake inhibitors (SSRIs). In addition, 5-HT(3) blockade by mirtazapine helps to prevent nausea and vomiting. Weight gain is the most commonly reported side-effect of mirtazapine, although there is evidence to suggest that this is not a significant problem during long-term treatment. In conclusion, mirtazapine has a good tolerability and safety profile that demonstrates several benefits over other antidepressants.
去甲肾上腺素能和特异性5-羟色胺能抗抑郁药(NaSSA)米氮平的耐受性和安全性特征反映了其独特的药理特性。5-羟色胺(5-HT)2阻断作用有助于其抗焦虑作用以及对睡眠的益处,还能预防如选择性5-羟色胺再摄取抑制剂(SSRI)等药物非特异性刺激5-羟色胺系统时可能出现的性功能障碍。此外,米氮平对5-HT3的阻断作用有助于预防恶心和呕吐。体重增加是米氮平最常报道的副作用,不过有证据表明在长期治疗期间这并非严重问题。总之,米氮平具有良好的耐受性和安全性特征,相较于其他抗抑郁药有多种益处。